technetium tc 99m sestamibi has been researched along with Adenocarcinoma, Papillary in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kasner, DL; Mulligan, GM; Nguyen, T; Spieth, ME | 1 |
Abe, M; Miyagawa, M; Nishimura, K; Ohnishi, H | 1 |
Higashi, T; Iida, Y; Ishimori, T; Iwata, M; Kasagi, K; Konishi, J; Matsumoto, K; Misaki, T; Nakamoto, Y; Saga, T | 1 |
Asahara, R; Kawakami, K; Kobayashi, M; Mogami, T; Mori, Y; Moriya, E; Ohtani, Y; Uchiyama, M | 1 |
1 trial(s) available for technetium tc 99m sestamibi and Adenocarcinoma, Papillary
Article | Year |
---|---|
Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sodium; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Treatment Outcome; Whole-Body Counting | 2004 |
3 other study(ies) available for technetium tc 99m sestamibi and Adenocarcinoma, Papillary
Article | Year |
---|---|
Incidental thyroid carcinoma on parathyroid imaging.
Topics: Adenocarcinoma, Papillary; Biopsy, Needle; Female; Humans; Middle Aged; Neoplasms, Multiple Primary; Parathyroid Glands; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thyroid Nodule; Ultrasonography | 2002 |
Tl-201, Tc-99m sestamibi, and Tc-99m HMDP uptake in multiple brown tumors.
Topics: Adenocarcinoma, Papillary; Bone Neoplasms; Clavicle; Female; Humans; Middle Aged; Parathyroid Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Ribs; Sternum; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Thallium; Whole-Body Counting | 2003 |
[Usefulness of 99mTc-MIBI SPECT in the metastatic lesions of thyroid cancer].
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Humans; Male; Middle Aged; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 1997 |